Meditoxin 100unit Regulatory Status: Professional Sourcing Guide

Meditoxin 100unit is a botulinum toxin type A product manufactured by Medytox, a South Korean biopharmaceutical company. Presented in a 100-unit vial, it is intended strictly for professional medical aesthetic applications within clinics. Professionals sourcing this product often consider alternatives like Re N Tox 100unit or other options available within our comprehensive botulinum toxin / neurotoxin catalog. Understanding its regulatory standing is key for professional stock.

Meditoxin 100unit holds foundational regulatory clearance from the KFDA (South Korea), permitting its domestic distribution and export. Medytox facilities generally adhere to international Good Manufacturing Practice (GMP) standards. Meditoxin 100unit itself does not hold direct FDA approval in the United States. Its specific CE Mark status for direct EU marketing may vary, often leading to reliance on alternative import pathways. [VERIFY: Specific ISO 13485 certification for Meditoxin production if applicable.]

Meditoxin's market presence varies significantly worldwide. In the European Union and the United Kingdom, product access for clinics is frequently managed through parallel import channels, as direct marketing authorization may not be held. For GCC and LATAM countries, market availability is dictated by distinct national regulatory bodies and local product registrations. APAC markets, beyond South Korea, also exhibit diverse regulatory landscapes requiring individual verification for your clinic's compliance.

Parallel importing sources products from one legally approved market for import into another, bypassing the manufacturer's direct distribution. This pathway can offer competitive pricing for clinics, but demands heightened due diligence. Professionals must verify the legal import pathway, ensure cold chain integrity, and confirm all product documentation aligns with local regulatory requirements for legal use in their practice.

When procuring Meditoxin 100unit, professionals must demand comprehensive documentation from suppliers. This includes Certificates of Authenticity, ensuring genuine origin, and traceable lot numbers. Verification of proper cold chain storage and transport is crucial for product efficacy. Referencing guides like the Hyaldew Regulatory Status: Market Access and Certification f offers broader context on essential certification demands for aesthetic injectables. Clinics should also verify adequate expiration dates upon receipt.

The illustrative wholesale price for Meditoxin 100unit is $77.0 per unit. Volume-based purchasing offers structured discounts for professional buyers. Clinics can expect tiered pricing, such as a 4% discount for 11 units, 5% for 21 units, 6% for 31 units, and 8% for 51+ units. This approach allows clinics to optimize procurement costs. For a comparative perspective on neurotoxin pricing, professionals may consult resources such as the Xeomin 200 Units Wholesale Price: A Guide for Professional S.